Adora Ndu, Pharm.D., J.D. has served as a director of our company since October 2022.
Dr. Ndu has served as Chief Regulatory Affairs Officer of BridgeBio Pharma Inc., a publicly traded biotechnology company, since January 2022. Prior to joining BridgeBio Pharma, Dr. Ndu served as Group Vice President, Worldwide Research & Development, Strategy, Scientific Collaborations and Policy at BioMarin Pharmaceutical, Inc. from January 2021 to January 2022. She previously served in positions of increasing responsibility at BioMarin, including as Vice President, Regulatory Affairs, Policy, Research, Engagement & International from August 2019 to January 2021, Executive Director from September 2017 to July 2019 and Senior Director from February 2017 to September 2019.
Prior to joining BioMarin, Dr. Ndu was an adjunct faculty member at the University of Maryland University College from 2016 to 2019 and served in various roles at the U.S. Food and Drug Administration from 2008 to 2016, most recently as a Division Director in the Division of Medical Policy Development. Dr. Ndu currently serves on the board of directors of DVB Technologies SA.
Dr. Ndu received her Doctor of Pharmacy from Howard University and her Juris Doctor from the University of Maryland Francis King Carey School of Law.